BridgeBio Pharma BBIO
NASDAQ BBIO
$79.54 +0.87 (+1.11%)
At close: Nov 11, 2026 · 4:00 PM EST

BridgeBio Pharma (BBIO) Ending Cash Balance (2018 - 2026)

Updated

BridgeBio Pharma's Ending Cash Balance came in at $1.54 billion for Q3 2026, up 138.0% from $645.1 million a year earlier and up 125.8% from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Ending Cash Balance (2018 - 2026) Analysis & Trends

For FY2025, BridgeBio Pharma's Ending Cash Balance was $572.14 million, down 16.3% from FY2024.

  • Ending Cash Balance carries a five-year compound annual growth rate of 9.8% (FY2020 to FY2025).
  • Going back by year, Ending Cash Balance was $683.24 million in FY2024 (+73.1%), $394.73 million in FY2023 (-5.3%), $416.88 million in FY2022 (+5.2%) and $396.37 million in FY2021 (+10.5%).
  • The Q3 2026 figure represents the highest quarterly Ending Cash Balance in data going back to Q4 2020.
  • Year-over-year, Ending Cash Balance increased in six of the last eight quarters, with growth averaging 44.6%.
  • The fastest year-over-year change in Ending Cash Balance over five years came in Q3 2022 (growth of 165.3%), and the weakest in Q2 2023 (a decline of 31.3%).
  • Business Quant data shows BBIO's Ending Cash Balance at $680.04 million (Q2 2026), $882.02 million (Q1 2026) and $572.14 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 16.91 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 7.94 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.88 Bn
10 BridgeBio Pharma 15.42 Bn 11.64 Bn 332.72 Mn 1.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.54 Bn
Jun 30, 2026 680.04 Mn
Mar 31, 2026 882.02 Mn
Dec 31, 2025 572.14 Mn
Sep 30, 2025 645.10 Mn
Jun 30, 2025 751.10 Mn
Mar 31, 2025 542.74 Mn
Dec 31, 2024 683.24 Mn
Sep 30, 2024 407.88 Mn
Jun 30, 2024 549.51 Mn
Mar 31, 2024 477.50 Mn
Dec 31, 2023 394.73 Mn
Sep 30, 2023 524.14 Mn
Jun 30, 2023 324.64 Mn
Mar 31, 2023 435.11 Mn
Dec 31, 2022 416.88 Mn
Sep 30, 2022 485.79 Mn
Jun 30, 2022 472.65 Mn
Mar 31, 2022 374.19 Mn
Dec 31, 2021 396.37 Mn
API Access

BridgeBio Pharma Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=BBIO&period=max&api_key=YOUR_API_KEY